Investor Relations
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Latest Financial Results
Q2 2020
Quarter Ended Jun 30, 2020
Stock Information
Company Overview
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Investor Contact Information
Company
Kane Biotech Inc.
162-196 Innovation Drive
Winnipeg, Manitoba R3T 2N2
Canada
T: 204.477.7592
ir@kanebiotech.com
Investor Relations
Harbor Access LLC
Graham Farrell
Managing Partner
130 King St. W
Suite 1900
Toronto, ON
T: (416) 842 9003
graham.farrell@harboraccessllc.com
Jonathan Paterson
Partner
320 Post Rd.
Darien, CT 06820
USA
T: (203) 862 0492
jonathan.paterson@harboraccessllc.com
Transfer Agent
Canadian Stock Transfer Company Inc.
600, 333 – 7th Avenue S.W.
Calgary, Alberta T2P 2Z1